Skip to content

Careers
News & Events

Search for:

Acurian Patient Engagement Services

Services
- Patient Enrollment
- Patient Retention
Experience
Methodology
Results
Contact Us

Search for:

Services
- Patient Enrollment
- Patient Retention
Experience
Methodology
Results
Contact Us

Careers
News & Events

Home / Acurian Saves Over Three Months of Enrollment Time for a Phase IIb Gastroesophageal Reflux Disease (GERD) Study / Acurian_case_study_Diabetes_Outcomes

Acurian_case_study_Diabetes_Outcomes

News

01/02/2019

Improving Clinical Trial Awareness and Recruitment

06/20/2018

Super-charged Screening for Patient Enrollment

06/20/2018

Patient Concierge

Did you know?

Major depressive disorder (MDD) trials have traditionally experienced low First Office Visit and Consent rates (FOV 20%, Consent 60%).

Participate in a clinical trial

Join our research-aware community of over 100 million people and we’ll notify you of clinical trials in your area.

Join now for free »

View our featured clinical trials:

View clinical trials »

Now that you know more about us, let’s help you achieve enrollment certainty, save you money and accelerate your race to market. Talk to us today about how our patients-first approach can help your current or next clinical trial.

Home
Privacy Policy
Terms of Use
Sitemap

LinkedIn

© 2019 Accelerated Enrollment Solutions (AES)